Accessibility Menu
 
RegenETP logo

RegenETP

(OTC) PTE

Current PriceN/A
Market CapN/A
Since IPO (2003)-100%
5 Year-99%
1 Year+668%
1 Month+2%

RegenETP Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$73.00K

Net Income (TTM)

$17.41M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About RegenETP

Industry

Biotechnology

Employees

44

CEO

Richard Hague

Headquarters

Salt Lake City, UT 84104, US

PTE Financials

Key Financial Metrics (TTM)

Gross Margin

24%

Operating Margin

-32%

Net Income Margin

13%

Return on Equity

57%

Return on Capital

-1%

Return on Assets

45%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Short Interest

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$198.00K

Operating Income

$25.88M

EBITDA

$6.23M

Operating Cash Flow

$22.60M

Capital Expenditure

$37.00K

Free Cash Flow

$22.63M

Cash & ST Invst.

$11.45M

Total Debt

$3.36M

RegenETP Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2023YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

$4.80M

-2020.8%

Gross Margin

0.00%

N/A

Market Cap

N/A

N/A

Market Cap/Employee

N/A

N/A

Employees

42

N/A

Net Income

$3.24M

-353.5%

EBITDA

$5.07M

-54.2%

Quarterly Fundamentals

Name
Q1 2023YOY CHG

Net Cash

$3.44M

-80.0%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

N/A

Long Term Debt

$2.50M

+642.6%

Short Term Debt

$458.00K

-61.3%

Return on Assets

44.69%

N/A

Return on Invested Capital

-1.25%

N/A

Free Cash Flow

$5.08M

+16.3%

Operating Cash Flow

$5.08M

+15.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ASLNASLAN Pharmaceuticals Limited
$0.60-14.27%
VBIVVBI Vaccines Inc.
$0.07-50.87%
ONCSQOncoSec Medical Incorporated
$0.00+0.00%
MTPMidatech Pharma plc
$0.29-18.50%

Trending Stocks

Symbol / CompanyPricePrice Chg
SKYQSky Quarry
$5.10+1.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$11.37-0.11%
INTCIntel
$50.38+0.05%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.33+0.00%

Questions About PTE

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.